Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00243048 · ClinicalTrials.gov registry record · Phase 2
Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer
A Phase 2 study, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT00243048 is a Phase 2 study that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 70 participants.
The verdict
NCT00243048, a Phase 2 study, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
RATIONALE: Eating a diet high in soy foods may slow the progression of some types of cancer. Isoflavones are compounds found in soy food that may slow the growth of prostate cancer cells and prevent further development of prostate cancer. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving isoflavones together with radiation therapy may be an effective treatment for prostate cancer. PURPOSE: This randomized phase II trial is studying the side effects and how well giving isoflavones together with radiation therapy works in treating patients with localized prostate cancer.
Interventions
- RADIATION radiation therapy
- DIETARY_SUPPLEMENT soy protein isolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2002-05 |
| Est. Completion | 2007-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00243048
The ClinicalTrials.gov registry entry for NCT00243048 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which radiation therapy is the first listed.
NCT00243048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00243048 about?
NCT00243048 is a clinical study titled "Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer". RATIONALE: Eating a diet high in soy foods may slow the progression of some types of cancer. Isoflavones are compounds found in soy food that may slow the growth of prostate cancer cells and prevent further development of prostate cancer. Radiation therapy uses high-energy x-rays to kill tumor cells...
What is the current status of trial NCT00243048?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2002-05. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00243048?
The interventions under investigation include: radiation therapy (RADIATION), soy protein isolate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00243048?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.